The deal gives Molson Coors exclusive commercialization rights to Fever-Tree’s U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc Partnership designed to fuel ...

Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

After two decades in Japan, one Canadian man shares some differences between life there and in his home country. Ron Reid, ...

Then “Pack Ice Season” arrived. That was the term the department of tourism was encouraging citizens to use in an attempt to ...

Proposed legislation requiring alcohol warning labels will be studied once Parliament resumes says Sen. Patrick Brazeau.

The Monday after the Big Game is notorious for being the Mondayest Monday for football fans. Just ask 60% of Americans and ...

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...

Molson Coors Beverage has partnered with Fever-Tree Drinks plc to expand its U.S. non-alcoholic drink portfolio. Starting ...

The London-listed mixer-maker said Molson Coors would acquire an 8.5% shareholding in Fevertree.

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer, worth $89 million, further builds on its long-term strategy of increasing its exposure beyond beer.